Advertisement Emisphere names vice president of strategy and development - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Emisphere names vice president of strategy and development

Emisphere Technologies, a biopharmaceutical company, has appointed Nicholas Hart as vice president of strategy and development. Mr Hart will be responsible for the planning and commercial development aspects of the company's Eligen technology, including Eligen B12.

Mr Hart comes to Emisphere with over 16 years of commercial experience in the pharmaceutical industry. In his most recent capacity at Organon, part of Schering Plough, he was leader of the contraception therapy area and a member of the corporate executive leadership team.

Also at Organon, he served as senior director and executive director of marketing of the women’s healthcare franchise; director of CNS marketing, and associate director of specialty products. Prior to Organon, Mr Hart held various marketing and sales positions with Novartis, Sankyo Parke Davis Pharmaceuticals and Bristol-Myers Squibb.

Michael Novinski, president and CEO of Emisphere, said: “I am delighted Nick Hart has joined our team at Emisphere to help us commercialize our Eligen technology, including Eligen B12. He brings a tremendous wealth of experience and a successful track record of accomplishment in the pharmaceutical industry. He has a demonstrated skill set both strategically and operationally, and I am confident that this track record will be continued at Emisphere.”